Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) reached a new 52-week low during trading on Thursday . The company traded as low as $12.65 and last traded at $12.65, with a volume of 2157 shares. The stock had previously closed at $12.94.

Cardiovascular Systems Trading Up 0.2 %

The stock has a fifty day moving average of $15.04 and a 200 day moving average of $16.83. The company has a debt-to-equity ratio of 0.08, a quick ratio of 5.19 and a current ratio of 6.05. The company has a market capitalization of $531.38 million, a PE ratio of -13.61 and a beta of 0.97.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CSII. Point72 Hong Kong Ltd purchased a new position in Cardiovascular Systems in the 2nd quarter worth approximately $34,000. Acadian Asset Management LLC raised its holdings in shares of Cardiovascular Systems by 294.7% during the 4th quarter. Acadian Asset Management LLC now owns 2,684 shares of the medical device company's stock worth $50,000 after acquiring an additional 2,004 shares in the last quarter. Signaturefd LLC raised its holdings in shares of Cardiovascular Systems by 8,110.3% during the 1st quarter. Signaturefd LLC now owns 2,381 shares of the medical device company's stock worth $54,000 after acquiring an additional 2,352 shares in the last quarter. PNC Financial Services Group Inc. raised its holdings in shares of Cardiovascular Systems by 32.1% during the 1st quarter. PNC Financial Services Group Inc. now owns 3,025 shares of the medical device company's stock worth $68,000 after acquiring an additional 735 shares in the last quarter. Finally, Nisa Investment Advisors LLC raised its holdings in shares of Cardiovascular Systems by 54.3% during the 1st quarter. Nisa Investment Advisors LLC now owns 3,495 shares of the medical device company's stock worth $79,000 after acquiring an additional 1,230 shares in the last quarter. 91.72% of the stock is owned by hedge funds and other institutional investors.

About Cardiovascular Systems

Cardiovascular Systems, Inc, a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.

See Also

• Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
• The Institutions Hold On To Darden Restaurants International
• What Steelcase's Earnings Say About the Return to the Office?
• Is The Golden Age Of Homebuilding Already Over?
• These 3 Big Dividend Payers Also Boast Strong Price Growth
• Natural Gas Prices Continue To Rally, These Stocks Should Benefit

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.